Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-02-22FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi Aria (golimumab) from Janssen Biotech, Inc., under BLA125433, to update the product …
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) [Phase 3]
Phase 3 trial results show efficacy of Secukinumab in active psoriatic arthritis at 24 weeks with long-term safety and tolerability data up …
-
FDA label_change · 2016-01-08FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI ARIA (golimumab) to update the product labeling.
-
FDA approval · 2015-12-21FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for OTEZLA (apremilast) from Amgen that updated its labeling.
-
CLINICAL_TRIALS withdrawal · 2015-12-02Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
The study evaluating golimumab in Filipino patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis has been with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis [Phase 2]
Phase 2 trial evaluating the efficacy of AIN457 in adults with psoriatic arthritis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis [NA]
The study evaluated the effectiveness of resistance training in patients with psoriatic arthritis and has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
A completed clinical trial evaluating dendritic cell-specific transmembrane protein (DC-Stamp) as a biomarker in psoriatic arthritis.
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? [Phase 3]
A Phase 3 trial update reports results on whether the anti-inflammatory drug etanercept modulates inflammation in inflammatory rheumatisms, …
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis [Phase 1]
A Phase 1 multiple-dose study of UCB4940 in subjects with psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab
A completed Greek clinical trial evaluated how adalimumab affects work productivity and sleep in patients with rheumatic diseases treated wi…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis [Phase 3]
Pfizer's Phase 3 long-term study of CP-690,550 (tofacitinib) in adults with moderate-to-severe plaque psoriasis and/or psoriatic arthritis h…
-
FDA label_change · 2015-08-05FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi Aria (golimumab) filed by Janssen Biotech, Inc., resulting in changes to the product lab…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis [Phase 3]
Phase 3b study assessing safety and efficacy of apremilast for moderate to severe plaque psoriasis and psoriatic arthritis has completed wit…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
A completed multi-country post-marketing observational study assessing the maintenance of effectiveness of adalimumab (Humira) in Ankylosing…
-
FDA approval · 2015-06-19FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) submitted by Pfizer Laboratories Div Pfizer Inc. The approval updates the …
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: TIght COntrol of Psoriatic Arthritis [Phase 3]
A Phase 3 clinical trial investigating tight control of psoriatic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
This clinical trial update reports results on the prevalence and incidence of articular symptoms related to psoriatic arthritis in patients …
-
FDA label_change · 2015-04-27FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
FDA announces that Amgen's supplemental application for OTEZLA (apremilast) has been approved, updating the product labeling accordingly.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector [EARLY_Phase 1]
The completed early-phase trial evaluated the design, functionality, and ergonomic features of an autoinjector intended for use in rheumatoi…
-
FDA approval · 2015-03-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept), expanding its label with additional indications. The submission status indi…
-
FDA approval · 2015-01-21FDA Approved: COSENTYX — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved the original Biologics License Application for Cosentyx (secukinumab) from Novartis Pharmaceuticals Corporation, establishing i…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) [NA]
This clinical trial evaluated how oral and intestinal microbiota may influence rheumatoid arthritis and related conditions, with results pos…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice
The study reports efficacy and safety results of Humira (adalimumab) in patients with psoriatic arthritis treated in routine clinical practi…